Pursuing remission is not chasing a miracle. It’s a goal grounded in evidence, access and awareness, and it is possible for many patients with chronic inflammatory conditions. Yet persistent myths still hold many people back.
Here’s what 2025 taught us about what remission really means – and what it doesn’t.
Myth #1: Patients with chronic illnesses are bound to have constant pain.
While pain is common in many chronic conditions, persistent, unrelenting pain is not inevitable. Modern treatment strategies aim for minimal or no pain most of the time, even when occasional flare-ups occur. Research published by the Global Remission Coalition shows that remission is often possible when patients are diagnosed promptly and work closely with their health care provider to access the treatment and support that is right for them.
Myth #2: Remission only applies to cancer.
Although the term is commonly linked with cancer care, remission is also relevant across other disease states. This year, the GRC convened patient advocates worldwide to highlight the importance of remission in chronic inflammatory conditions – including skin conditions, inflammatory bowel disease and rheumatic conditions. Remission can and should be a goal well beyond oncology.
Myth #3: Remission means you’re cured.
Remission often refers to the absence of disease signs and symptoms – but that doesn’t mean the condition is cured. Remission is a meaningful milestone that improves quality of life, but it requires upkeep. Ongoing monitoring, continued treatment and regular conversations with providers help patients maintain remission and address changes early.
Myth #4: Remission happens on its own if you wait long enough.
Remission is not a passive occurrence. It requires proactive, ongoing communication with a health care provider. Patients should feel empowered to share symptoms openly and explore treatment options that align with their needs and goals. Clear dialogue supports informed decisions – and keeps remission within reach.
Myth #5: Health care systems prioritize remission.
Unfortunately, health systems do not prioritize remission. But that can change.
Current care tends to be reactive, addressing disease only once it has progressed – which makes remission harder to achieve. A better approach is to be proactive: early diagnosis, primary care-level screening, broader awareness among patients and providers and strong cross-specialty collaboration.
Looking Ahead
In 2025, the Global Remission Coalition, alongside its membership comprising over 70 advocacy organizations, advanced patient-centered policies that elevate remission as a priority. Through global meetings and multilingual educational resources, the GRC delivered a clear message: the pursuit is on.
In 2026, the GRC is committed to building on this momentum and putting remission firmly on the policy agenda across the globe.